Alopecia is the medical term for hair loss and comes from the Greek word alōpekía referring to the skin condition, mange, in foxes. Alopecia areata causes a unique form of hair loss different to the more common age-related male and female pattern hair loss.
Alopecia Areata clinical study for teenagers
This clinical study aims to evaluate the efficacy and safety of Baricitinib (oral) in adolescents with alopecia areata.
We are recruiting participants who:
- Are age 12 - 17 years old
- Have AA for ≥ 1 year
- Have ~50% of hair loss
- Have not been previously treated with Baricitinib
About the study
- Study period: 9 months
- Participants will be required to attend monthly visits at our East Melbourne clinic.
- There will be no cost to participate.
- Eligible participants will be reimbursed for their time and travel.
Your next steps
- Fill out your contact details below.
- Our recruitment team will give you a call to discuss your eligibility and more details about the study.